ReviewNature reviews. Cancer2019
The evolving landscape of biomarkers for checkpoint inhibitor immunotherapy.
Jonathan J Havel et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1,396 papers cite itlatest 60 shown
this paperpooled ittrialcites it